Dr Reddys
TCS, Infosys, and Dr Reddy's shares hit fresh record highs
India's coronavirus drug market set for price war as firms ready launches
Covid-19 crisis: Made-in-India remdesivir may come by end of June
Revised Wockhardt deal boosts prospects of Dr Reddy's India business
Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business

Dr Reddy's gets USFDA inspection closure report fo Srikakulam unit
Dr Reddy's Labs hits over 4-year high, surges 62% from March low
Dr Reddy's board approves borrowing of Rs 2,000 cr through multiple routes
USFDA seeks voluntary action at Dr Reddy's Andhra Pradesh facility
Diabetes to be our focus in India, US: Wockhardt's Habil Khorakiwala

New launches, regulatory go-ahead key triggers for Dr Reddy's
Top headlines: Air India's 100% stake sale; 1,000 frauds in 5 years at UCBs
Stock recommendation from Prabhudas Lilladher: Buy Dr Reddy's, GAIL
Dr Reddy's falls 5% as rival firm beats Co to US FDA approval for EluRyng
Technical calls by Religare Broking: Buy Dr Reddy's Lab, Ramco Cements
Dr Reddy's gets 4 observations from USFDA for Srikakulam plant
Dr Reddy's Laboratories recalls anti-ulcer drug ranitidine from US market
Dr Reddy's Labs shines among pharma stocks, wins investor confidence
Dr Reddy's halts worldwide supply of Ranitidine drug after probe by USFDA
Regulatory worries, price erosion may pull down Dr Reddy's US revenues